Filings & corporate actions
- 11 NovrightsRights 5:12 @ Premium Rs 855/- · record 11 Nov 2026-15.9%
Growth
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Profit | — | — | — | — | — | — |
Key data
Delivery percentage
Over the last 20 sessions EVONILE settled 51.2% of its traded quantity, which is above average for an NSE equity. Its one-year average is 53.2%, so recent sessions are running 2.0 points lower than usual.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -4.35% | -13.54% | -23.53% | -1.80% | +27.30% | — |
Valuation
Ownership
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2023-24 | 1 | ₹47.50 | ₹47.50 |
| FY2022-23 | 1 | ₹10.00 | ₹10.00 |
| FY2021-22 | 1 | ₹10.00 | ₹10.00 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 20 Jul 2023 | — | ₹47.50 | ₹47.50 |
| 20 Jul 2022 | — | ₹10.00 | ₹10.00 |
| 17 Aug 2021 | — | ₹10.00 | ₹10.00 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
52-week highs & lows
Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.
Price-band hits
Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.
Book closures & record dates
NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.
Short selling, lending & margin
Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.
Exchange surveillance
- High-low range > 150% in 12 months · since 30 Oct 2026 — One of the criteria NSE’s surveillance watches: high-low range > 150% in 12 months.
- High-low range > 100% in 6 months · since 14 Oct 2026 — One of the criteria NSE’s surveillance watches: high-low range > 100% in 6 months.
- High-low range > 75% in 3 months · since 28 Sept 2026 — One of the criteria NSE’s surveillance watches: high-low range > 75% in 3 months.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →EVONILE at a glance
- EVONILE closed at ₹1,520.4 on 13 Nov 2026, -4.35% on the day.
- Delivery was 54.8% of traded quantity on 13 Nov 2026, the 51st percentile of its own 144 sessions with a reading (20-session average 51.2%, 1-year average 53.2%).
- Market capitalisation is ₹3,754 crore, with no positive trailing earnings for a P/E.
About
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 13 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,442.00-0.37%
- LALAURUSLABSLaurus Labs Limited2,424.00+1.00%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,880.00-0.27%
- ACACUTAASAcutaas Chemicals Limited4,039.10+1.08%
- SASAILIFESai Life Sciences Limited1,928.80+1.24%
- DRDRREDDYDr. Reddy's Laboratories Limited1,380.00-0.48%
- PPPPLPHARMAPiramal Pharma Limited244.54-0.22%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,640.00-0.74%
- AUAUROPHARMAAurobindo Pharma Limited1,823.20+0.89%
- MAMANKINDMankind Pharma Limited2,640.00+0.05%
- ZYZYDUSLIFEZydus Lifesciences Limited1,189.90-1.33%
- CICIPLACipla Limited1,391.80-1.17%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE